These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20093654)

  • 1. Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time!
    Humbert M; Simonneau G
    Am J Respir Crit Care Med; 2010 Feb; 181(3):202-3. PubMed ID: 20093654
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
    Franz IW; Van Der Meyden J; Schaupp S; Tönnesmann U
    Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators.
    Burger CD
    COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - contra].
    Köhler D
    Dtsch Med Wochenschr; 2008 Apr; 133(14):721. PubMed ID: 18363193
    [No Abstract]   [Full Text] [Related]  

  • 8. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease.
    Dernaika TA; Beavin M; Kinasewitz GT
    Respiration; 2010; 79(5):377-82. PubMed ID: 19786728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil in older patients with secondary pulmonary hypertension.
    Minotti GC; Corsonello A; Incalzi RA
    J Am Geriatr Soc; 2007 Oct; 55(10):1681-2. PubMed ID: 17908072
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilators ineffective in secondary pulmonary hypertension.
    Dash H; Ballentine N; Zelis R
    N Engl J Med; 1980 Oct; 303(18):1062-3. PubMed ID: 7421904
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacologic effects of peripheral vasodilators in patients with secondary pulmonary hypertension].
    Kukes VG; Tsoĭ AN; Abrosimov AG; Nasyrov ShN; Belov AM
    Klin Med (Mosk); 1989 May; 67(5):52-6. PubMed ID: 2671486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD.
    Reed RM; Iacono A; DeFilippis A; Jones S; Eberlein M; Lechtzin N; Girgis RE
    COPD; 2011 Apr; 8(2):96-102. PubMed ID: 21495837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhaled vasodilators].
    Zwissler B
    Anaesthesist; 2002 Aug; 51(8):603-24. PubMed ID: 12391520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do vasodilators have a role in the treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies?].
    Weitzenblum E; Mammosser M
    Rev Mal Respir; 1985; 2(6):337-8. PubMed ID: 3835609
    [No Abstract]   [Full Text] [Related]  

  • 17. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L; Yang YH; Cui N; Xie WM; Zhai ZG; Ma ZH; Wang C
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2103-5. PubMed ID: 20058612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prostanoids in the treatment of pulmonary arterial hypertension].
    Başkurt M; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction.
    Sheth A; Park JE; Ong YE; Ho TB; Madden BP
    Vascul Pharmacol; 2005 Jan; 42(2):41-5. PubMed ID: 15722248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.